3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
18
Melanoma
12
Colorectal Neoplasms
8
Lung Neoplasms
7
Ovarian Neoplasms
6
Neoplasms
5
Mesothelioma, Malignant
5
Carcinoma, Renal Cell
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Merkel Cell
4
Uterine Cervical Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Carcinoma, Transitional Cell
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Skin Neoplasms
2
Sarcoma
2
Recurrence
2
Prostatic Neoplasms
2
Pleural Effusion, Malignant
2
Lymphoma
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Adenocarcinoma of Lung
2
Uveal Melanoma
1
Interventions
pembrolizumab
7
Ipilimumab
5
Nivolumab
4
fludarabine
3
Radiosurgery
3
Drug Therapy
3
Cyclophosphamide
3
spartalizumab
2
aldesleukin
2
Sirolimus
2
Riluzole
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Oncolytic Virotherapy
2
Counseling
2
Bupropion
2
Blood Specimen Collection
2
vofatamab
1
utomilumab
1
trastuzumab deruxtecan
1
toripalimab
1
tocilizumab
1
sargramostim
1
saracatinib
1
pertuzumab
1
pazopanib
1
liposomal doxorubicin
1
ixabepilone
1
fostamatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Interleukin-2
×
Thoracic
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled